All Public Health articles – Page 4
-
NewsGlobal Virus Network issues scientific guidance on new COVID-19 variant NB.1.8.1 and vaccine protection
The Global Virus Network (GVN) is closely monitoring the emergence of a newly identified SARS-CoV-2 variant, NB.1.8.1, a sublineage of the Omicron family first identified in January 2025 and which has rapidly spread across Asia and into other regions.
-
NewsPregnant women in frontline of measles outbreaks in Canada
Measles is on the rise in Canada and poses serious risks to pregnant women and their newborns, yet discussion about how to protect this vulnerable group is notably lacking. Physicians working directly with measles outbreaks have summarized key points for clinicians.
-
NewsGlobal study: COVID-19 and adenoviral vaccines tied to GBS risk, not mRNA vaccines
A large-scale study in a population covering more than 230 million people sheds light on the relationship between Guillain-Barré syndrome after COVID-19 vaccines or SARS-CoV-2 infection.
-
NewsNew data shows MMR vaccination rate decline across US
A new county-level dataset reveals a national decline in the measles-mumps-rubella (MMR) vaccination rate among U.S. children since the start of the COVID-19 pandemic.
-
NewsEarlier measles vaccine could help curb global outbreak
The global measles outbreak must trigger an urgent debate into whether a vaccine should be recommended earlier to better protect against the highly contagious disease during infancy, a new review states.
-
NewsGlobal leaders reaffirm commitment to WHO with at least US$ 170 million raised at World Health Assembly 2025 pledging event
World leaders pledged at least an additional US$ 170 million to the World Health Organization (WHO) at a high-level pledging event Tuesday at the Seventy-eighth World Health Assembly in Geneva.
-
NewsWorld Health Assembly adopts historic Pandemic Agreement to make the world more equitable and safer from future pandemics
Member States of the World Health Organization (WHO) today formally adopted by consensus the world’s first Pandemic Agreement, following more than three years of intensive negotiations launched by governments in response to the COVID-19 pandemic.
-
NewsWHO validates Mauritania for eliminating trachoma as a public health problem
The World Health Organization (WHO) has validated Mauritania as having eliminated trachoma as a public health problem, making it the seventh country in WHO’s African Region to achieve this significant milestone.
-
NewsGenomic data shows widespread mpox transmission in West Africa prior to 2022 global outbreak
Mpox was transmitted among humans in Nigeria for eight years before sparking the international outbreak in 2022. Using genomic tracing, the researchers estimate that the virus’s ancestor first emerged in southern Nigeria in August 2014.
-
NewsPapua New Guinea eliminates trachoma as a public health problem
Papua New Guinea (PNG) has been validated by the World Health Organization (WHO) for eliminating trachoma as a public health problem. Trachoma, the world’s leading infectious cause of blindness, no longer poses a public health threat in the country.
-
NewsAmericans say benefits of MMR vaccine for children outweigh risks by nearly 5-1
While many Americans know how measles can spread, most cannot accurately estimate the prevalence of complications associated with measles such as hospitalization or the risks it presents during pregnancy, according to a new survey.
-
NewsThe Global Fund to fight AIDS, Tuberculosis and Malaria ‘should step up efforts’
The international community must protect global responses to HIV, tuberculosis (TB), and malaria to serve humanity’s collective interests, according to a new opinion article.
-
NewsFoot traffic can predict COVID-19 spread in New York City neighborhoods
A new study reveals how foot traffic data from mobile devices can enhance neighborhood-level COVID-19 forecasts in New York City, providing a novel approach to predicting the spread of the SARS-CoV-2 virus and improving targeted public health interventions.
-
NewsNew study reveals emerging cases of babesiosis in Mid-Atlantic region
A newly published study provides critical insights into the emergence of babesiosis in the Mid-Atlantic region, documenting human cases and the presence of Babesia microti in local tick populations.
-
NewsNational-level actions effective at tackling antibiotic resistance
National-level policies can reduce the impact of antibiotic resistance across diverse countries, according to a new study. The comparison of countries found that national action was consistently associated with improved indicators of antibiotic resistance.
-
NewsMeasles may be making a comeback in the US, research finds
If immunization rates drop further over a prolonged period of time, measles and even other wiped-out diseases — such as rubella and polio — could one day make a comeback in the United States, according to a new study.
-
NewsGlobal virus network issues urgent call to action to mitigate the rising threat of H5N1 avian influenza
The Global Virus Network (GVN) has issued a call-to-action, calling on world governments to address the threat of H5N1 avian influenza by enhancing surveillance, implementing biosecurity measures, and preparing for potential human-to-human transmission.
-
NewsEvery dose counts: Safeguarding the success of vaccination in Europe
Marking European Immunization Week (EIW) 2025, a new report highlights the risks of suboptimal vaccination coverage in Europe and publishes a set of operational tools that public health authorities can use to improve vaccination acceptance and uptake.
-
NewsHospital-based outbreak detection system saves lives
An infectious diseases detection platform has proved over a two-year trial that it stops outbreaks, saves lives and cuts costs. The results make the case for adoption in hospitals nationwide and the development of a national early outbreak detection database.
-
NewsSuccess of agile COVID-19 pan-Canadian research network highlights how to tackle future pandemics
The operations of CoVaRR-Net, a national interdisciplinary research network initiated to study COVID-19 variants and enhance Canada’s preparedness for future pandemics, have concluded following the expiration of funding.